Cart
sales@molnova.com
Heteroclitin G
CAS No. 144027-74-7
Heteroclitin G( —— )
Catalog No. M29424 CAS No. 144027-74-7
Heteroclitin G was found as potential biomarkers of KIS blood-replenishing activity, and quantitative analysis provided a research basis for further pharmacological research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 171 | In Stock |
|
| 5MG | 143 | In Stock |
|
| 10MG | 207 | In Stock |
|
| 25MG | 351 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHeteroclitin G
-
NoteResearch use only, not for human use.
-
Brief DescriptionHeteroclitin G was found as potential biomarkers of KIS blood-replenishing activity, and quantitative analysis provided a research basis for further pharmacological research.
-
DescriptionHeteroclitin G was found as potential biomarkers of KIS blood-replenishing activity, and quantitative analysis provided a research basis for further pharmacological research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number144027-74-7
-
Formula Weight400.42
-
Molecular FormulaC22H24O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=C2C([C@H](O)[C@@]([C@H](C)C3)(C)[C@@]24C3=CC(OC)=C(OC)C4=O)=CC5=C1OCO5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(Phenylac-Tyr1,D-Arg...
JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. JV-1-36 inhibits the production of reactive oxygen species in A549 lung cancer cells. JV-1-36 can be used to study the effect of GHRH antagonists in vitro .
-
Mitazalimab
Mitazalimab (ADC-1013; JNJ-64457107) is an FcγR-dependent CD40 agonist that targets tumors by activating antigen-presenting cells like dendritic cells (DC), initiating tumor-reactive T cells, promoting tumor-specific T cell infiltration and destruction of tumors, and remodeling the tumor-infiltrating myeloid microenvironment .
-
MSC-4106
MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .
